{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:31:16Z","timestamp":1788957076116,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijrobp.2015.01.008","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T22:03:06Z","timestamp":1428530586000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the\u00a0International Lymphoma Radiation Oncology Group"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6902-2190","authenticated-orcid":false,"given":"Lena","family":"Specht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Illidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.01.008_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases","volume":"52","author":"Kirova","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib7","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: A comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib9","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: Clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib11","unstructured":"NCCN Clinical Practice Guidelines in Oncology, Non-Hodgkin\u2019s Lymphomas Version 1.2015. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf. Last accessed Feb. 17, 2015)."},{"key":"10.1016\/j.ijrobp.2015.01.008_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib13","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.ijrobp.2007.08.077","article-title":"Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy","volume":"70","author":"Yu","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib15","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib16","first-page":"204","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy\u2014diagnostic and therapeutic challenges","volume":"9","author":"Wobser","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1097-0142(20001015)89:8<1835::AID-CNCR26>3.0.CO;2-H","article-title":"Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma","volume":"89","author":"Heinzerling","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib19","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: Validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib21","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): Part II. Prognosis, management, and future directions","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archdermatol.2010.101","article-title":"Folliculotropic mycosis fungoides: Single-center study and systematic review","volume":"146","author":"Lehman","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2012.05.034","article-title":"Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma","volume":"85","author":"Thomas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0360-3016(77)90182-1","article-title":"The rationale for curative radiotherapy in mycosis fungoides","volume":"2","author":"Hoppe","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib28","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","article-title":"Revisiting low-dose total skin electron beam therapy in mycosis fungoides","volume":"81","author":"Harrison","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2133.2011.10670.x","article-title":"Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: An open-label prospective phase II study","volume":"166","author":"Kamstrup","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5114\/pdia.2013.33379","article-title":"Total skin electron irradiation techniques: A review","volume":"30","author":"Piotrowski","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ijrobp.2004.02.046","article-title":"Matching the dosimetry characteristics of a dual-field Stanford technique to a customized single-field Stanford technique for total skin electron therapy","volume":"59","author":"Chen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0360-3016(90)90075-U","article-title":"Development of total-skin electron therapy at two energies","volume":"18","author":"Cox","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: Radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.rpor.2013.05.002","article-title":"Institutional experience with a rotational total skin electron irradiation (RTSEI) technique\u2014a three decade review (1981-2012)","volume":"19","author":"Evans","year":"2014","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rpor.2013.07.002","article-title":"Technical and dosimetric aspects of the total skin electron beam technique implemented at Heidelberg University Hospital","volume":"19","author":"Hensley","year":"2014","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1259\/0007-1285-57-678-501","article-title":"Clinical aspects of a rotational total skin electron irradiation","volume":"57","author":"Kim","year":"1984","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/130.2.493","article-title":"Total-body superficial electron-beam therapy using a multiple-field pendulum-arc technique","volume":"130","author":"Sewchand","year":"1979","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2015.01.008_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0360-3016(97)00141-7","article-title":"Lying-on position of total skin electron therapy","volume":"39","author":"Wu","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:53:33Z","timestamp":1566521613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0360301615000279"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the\u00a0International Lymphoma Radiation Oncology Group","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}